Suppr超能文献

成人首次无诱因强直阵挛发作后的复发风险。

Risk of recurrence after first unprovoked tonic-clonic seizure in adults.

作者信息

Bora I, Seçkin B, Zarifoglu M, Turan F, Sadikoglu S, Ogul E

机构信息

Department of Neurology, Faculty of Medicine, Uludag University, Bursa, Turkey.

出版信息

J Neurol. 1995 Feb;242(3):157-63. doi: 10.1007/BF00936889.

Abstract

The likelihood of seizure recurrence after a first unprovoked seizure has profound social, vocational and emotional implications for the patients. Recurrence rates have varied between 27% and 71% in various studies, and the management of patients with a single unprovoked seizure is a controversial topic. In this prospective study we investigated the influence of age, sex, family history, EEG patterns, and anticonvulsant drug (ACD) therapy on seizure recurrence after a first unprovoked tonic-clonic seizure in adults. For this purpose, between October 1988 and January 1991, we studied adult patients who had experienced their after unprovoked tonic-clonic seizure within last 2 months before neurological consultation, and followed them until June 1993. There were 147 patients who met the criteria for inclusion. Overall cumulative recurrence rates were 31.8% by 6 months, 41.3% by 1 year, 44.1% by 2 years, 42.2% by 3 years, and 45.2% by 4 years. Among the risk factors that were evaluated, the time of the day at which the initial seizure occurred was associated significantly (P < 0.05) with seizure recurrence. In our series, 62 patients received ACD and 85 did not. We did not find a significant difference in recurrence rate with regard to ACD therapy. Our results are comparable with those of studies reported previously and suggest that the majority of recurrences after a first unprovoked seizure were seen in the first year (in our series 89% of all recurrences). In our study there was no significant predictor of seizure recurrence, except the time of day at which the initial seizure occurred.

摘要

首次无诱因发作后癫痫复发的可能性对患者有着深远的社会、职业和情感影响。在各项研究中,复发率在27%至71%之间波动,而对于单次无诱因发作患者的管理是一个存在争议的话题。在这项前瞻性研究中,我们调查了年龄、性别、家族史、脑电图模式和抗惊厥药物(ACD)治疗对成人首次无诱因强直阵挛发作后癫痫复发的影响。为此,在1988年10月至1991年1月期间,我们研究了在神经科会诊前最后2个月内经历首次无诱因强直阵挛发作的成年患者,并对他们进行随访直至1993年6月。共有147名患者符合纳入标准。6个月时的总体累积复发率为31.8%,1年时为41.3%,2年时为44.1%,3年时为42.2%,4年时为45.2%。在评估的风险因素中,首次发作发生的时间与癫痫复发显著相关(P < 0.05)。在我们的研究系列中,62名患者接受了ACD治疗,85名未接受。我们未发现ACD治疗在复发率方面存在显著差异。我们的结果与先前报道的研究结果相当,表明首次无诱因发作后的大多数复发发生在第一年(在我们的研究系列中,所有复发的89%)。在我们的研究中,除了首次发作发生的时间外,没有癫痫复发的显著预测因素。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验